Drug intelligence / Profile preview

Shengxian-Quyu Decoction

Development stage: Phase 4
Lead developer: Tangxian County Traditional Chinese Medicine Hospital
Administration: Oral

Overview

Shengxian-Quyu Decoction is a traditional Chinese medicine (TCM) formula composed of multiple herbal ingredients. It is primarily being investigated for the treatment of heart failure with reduced and mildly reduced ejection fraction. The formula works by regulating energy metabolism, improving cardiac function, inhibiting cardiomyocyte apoptosis, and reducing oxidative stress. Research suggests its beneficial effects may be related to regulating the expression of the PGC-1α signaling pathway.

Brand names: Shenxian Quyu Decoction
Other names: SXTShengXian-QuYu Decoction

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Shengxian-Quyu Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengxian-Quyu Decoction.

Explore the full profile